N@N

MYGN, APH, NUVA, BEAV, SLGN, ELGX Expected To Be Higher Leading Up To Next Earnings Releases

^{Published on 2009-07-13 09:57:51, Last Modified on 2010-12-22 14:28:50 - WOPRAI}
 

July 13, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and July/August earnings reports. Myriad Genetics (NASDAQ: MYGN), Amphenol Corp (NYSE: APH), NuVasive (NASDAQ: NUVA), BE Aerospace (NASDAQ: BEAV), Silgan Holdings (NASDAQ: SLGN) and Endologix (NASDAQ: ELGX) are all expected to be higher leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher leading up to their next earnings release:

Symbol Company # of Reports Quarter Release Date

MYGN Myriad Genetics Inc. 12 quarters Q4 8/25/2009

APH Amphenol Corporation July earnings Q2 7/16/2009

NUVA NuVasive, Inc. 12 quarters Q2 7/23/2009

BEAV B/E Aerospace, Inc. 12 quarters Q2 7/28/2009

SLGN Silgan Holdings Inc July earnings Q2 7/22/2009

ELGX Endologix Inc. July earnings Q2 7/22/2009

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event. because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Myriad Genetics, Inc. (NASDAQ: MYGN), a healthcare company, focuses on the development and marketing of novel molecular diagnostic products. It commercializes predictive medicine, personalized medicine, and prognostic medicine products. The company markets BRACAnalys for assessing a womana�s risk for breast and ovarian cancer; COLARIS molecular for assessing a persona�s risk of developing colorectal cancer or uterine cancer; COLARIS AP, a molecular diagnostic product for colon cancer that detects mutations in the APC and MYH genes; and MELARIS, which assesses a persons risk of developing melanoma. It also offers OnDose, a personalized medicine product to measure a patient's exposure to 5-FU chemotherapy; PREZEON that assesses loss of PTEN function in cancer patients; and TheraGuide 5-FU assesses a person's risk of developing a toxic reaction to 5-FU-based chemotherapy. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Amphenol Corporation (NYSE: APH) engages in the design, manufacture, and marketing of electrical, electronic, and fiber optic connectors and interconnect systems, and coaxial and flat-ribbon cables worldwide. It produces various interconnect products and assemblies primarily for voice, video, and data communication systems, commercial aerospace and military systems, automotive and mass transportation applications, and industrial and factory automation equipment. The companya�s interconnect products include connectors, which when attached to an electronic or fiber optic cable, a printed circuit board or other device, facilitate electronic or fiber optic transmission. Its interconnect assemblies consist of a system of cable and connectors for linking electronic and fiber optic equipment. The company also produces various radio frequency connector products and antennas for use in telecommunications, computer and office equipment, instrumentation equipment, local area networks, and automotive electronics, as well as in base stations, mobile communication devices, and other components of cellular and personal communications networks. In addition, it produces industrial interconnect products; and highly-engineered cable and backplane assemblies. The companya�s cable products comprise coaxial cable and connector products for use in cable television systems, including full service cable television/telecommunication systems. It also provides high speed data cables and specialty cables for use in computer and office equipment applications, as well as in various telecommunication applications. Amphenol Corporation markets its products directly, as well as through manufacturersa� representatives and distributors to original equipment manufacturers, contract manufacturers, cable system operators, and telecommunication companies. The company was founded in 1932 and is headquartered in Wallingford, Connecticut.

NuVasive, Inc. (NASDAQ: NUVA), a medical device company, engages in the design, development, and marketing of products for the surgical treatment of spine disorders. Its products are used in applications for spine fusion surgery. The companya�s products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines four categories of product offerings, including NeuroVision, a proprietary software-driven nerve avoidance system; MaXcess, a split-blade design retraction system providing enhanced surgical access to the spine; Biologics, which includes FormaGraft and Osteocel line of products; and specialized implants, such as SpheRx pedicle screw system, and CoRoent suite of implants, a titanium surgical mesh system with a line of precision-machined cervical and lumbar allograft implants, and related instrumentation. NuVasive also offers a range of bone allograft in patented saline packaging and spine implants, such as rods, plates, and screws, as well as Osteocel, a bone matrix product that offers three properties related to autograft, including osteoconduction, osteoinduction, and osteogenesis. The companya�s motion preservation products include lateral total disc replacement (TDR). It sells its products through independent sales agencies and direct sales representatives primarily in the United States. The company was founded in 1997 and is headquartered in San Diego, California.

BE Aerospace, Inc. (NASDAQ: BEAV) manufactures and markets cabin interior products for commercial aircraft and business jets worldwide. The company operates in three segments: commercial aircraft, consumables management, and business jet. The Commercial Aircraft segment manufactures a range of aircraft seats, including first class, business class, tourist class, and regional aircraft seats; seat frames, cushions, armrests, tray table, and various optional features, such as adjustable lumbar supports, footrests, reading lights, head/neck supports, and other comfort amenities; oxygen storage and delivery systems for commercial and business jet aircraft; aircraft coffee and beverage makers, and coffee warmers and water boilers; a line of ovens, including convection ovens, steam ovens, and warming ovens; commercial aircraft refrigeration equipment; and crew rest compartments. This segment also offers engineering, design, integration, installation, and certification services for commercial aircraft passenger cabin interiors; interior reconfiguration services; and in-house capabilities to design, manage, integrate, test, and certify reconfigurations and modifications for commercial aircraft. The consumables management segment provides inventory management and replenishment, electronic data interchange, special packaging and bar-coding, parts kitting, quality assurance testing, and purchasing assistance services; and distributes aerospace fasteners and consumables. The Business Jet segment manufactures a line of furnishings for business jets, including seating and sofa products comprising electric fully berthing lie flat seats, direct and indirect lighting, air valves and oxygen delivery systems, as well as sidewalls, bulkheads, credenzas, closets, galley structures, lavatories, and tables; and super first class cabin interior products for commercial wide-body aircraft. The company was founded in 1987 and is headquartered in Wellington, Florida.

Silgan Holdings, Inc. (NASDAQ: SLGN), through its subsidiaries, engages in the manufacture and sale of metal and plastic consumer goods packaging products in North America, Europe, Asia, and South America. Its products include steel and aluminum containers for human and pet food; and custom designed plastic containers, tubes, and closures for personal care, health care, pharmaceutical, household and industrial chemical, food, pet care, agricultural chemical, automotive, and marine chemical products. The company also offers metal, composite, and plastic vacuum closures for food and beverage products. Silgan Holdings markets its products through direct sales force and a network of distributors primarily to consumer products companies. The company was founded in 1987 and is based in Stamford, Connecticut.

Endologix, Inc. (NASDAQ: ELGX) engages in the development, manufacture, marketing, and sale of minimally invasive therapies for the treatment of vascular diseases. It offers Powerlink System, a catheter and endoluminal graft for the treatment of abdominal aortic aneurysm, a weakening of the wall of the aorta, an artery of the body. The Powerlink System consists of a self-expanding cobalt chromium alloy stent cage covered with an ePTFE graft; and is implanted in the abdominal aorta that is accessed through the femoral artery. Its Powerlink System shunts away the blood flow from the weakened or aneurysmal section of the aorta, reducing pressure and potential for the aorta to rupture. The Powerlink System includes infrarenal bifurcated systems, and aortic cuffs and limb extensions; and IntuiTrak to deliver and deploy the Powerlink stent graft. It sells its products primarily in the United States, Europe, and Japan. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is based in Irvine, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641